United States· US:65862-158_75754a95-33cf-4bfb-bee1-7d308a227250
carisoprodol
A carisoprodol product containing carisoprodol, registered in United States by Aurobindo Pharma Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Carisoprodol is registered in 3 of 19 countries.
Countries holding a registration under ATC M03BA02 (carisoprodol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Carisoprodol · ATC M03BA02
3 / 19 countries
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carisoprodol costs, country by country.
Normalised to the WHO defined daily dose (1.4 g), so markets compare like for like.
- United States: $0.28 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Carisoprodol · price per daily dose (1.4 g)
USD · FX 28 Sept 2026
- US United States$0.28 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CARISOPRODOL
- Manufacturer
- Aurobindo Pharma Limited
- Country
- United States (US)
- ATC code
- M03BA02
- ATC class
- Carisoprodol
- Defined daily dose
- 1.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc116586215801100 TABLET in 1 BOTTLE (65862-158-01)
- ndc116586215805500 TABLET in 1 BOTTLE (65862-158-05)
- ndc1165862158991000 TABLET in 1 BOTTLE (65862-158-99)
- ndc1165862-158-01
- ndc1165862-158-05
- ndc1165862-158-99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
214 interactions on record for carisoprodol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carisoprodol · interactions on record
214 records
- 4 severe
- 67 moderate
- 2 minor
- 141 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carisoprodol in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cddf3946-422e-41e7-8879-571a056a0c70 GET /v1/drugs/cddf3946-422e-41e7-8879-571a056a0c70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "350",
"substance": "CARISOPRODOL",
"productndc": "65862-158",
"dosage_form": "TABLET",
"dea_schedule": "CIV",
"strength_unit": "mg/1",
"application_number": "ANDA040792",
"marketing_category": "ANDA"
}See everything about carisoprodol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.